SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-17-000143
Filing Date
2017-08-24
Accepted
2017-08-24 11:19:33
Documents
1
Period of Report
2017-08-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5528
  Complete submission text file 0001235802-17-000143.txt   7112
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 BETHESDA METRO CENTER 14TH FLOOR BETHESDA MD 20814
Business Address
HARPER PHILIP R (Reporting) CIK: 0001181073 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 171048610